TP53 and neoplasm: Some associations between specific gene mutations and clinical data or histologic and molecular subtypes have been already described, such as the association of TP53 mutations with survival (Bueno et al., 2016), TERT promoter (TERT_prom) mutations with histology (Tallet et al., 2014), or BAP1 mutations with the C1 and the iCluster 1 subtypes, both enriched in MME tumor (de Reynies et al., 2014; Hmeljak et al., 2018).